中国经济网北京4月8日讯科净源（301372）(301372.SZ)昨晚发布关于收到中国证券监督管理委员会立 案告知书的公告。北京科净源科技股份有限公司于近日收到中国证券监督管理委员会(以下简称"中国证 监会")《立案告知书》(编号：证监立案字0142025023号)，因涉嫌信息披露违法违规，根据《中华人民 共和国证券法》《中华人民共和国行政处罚法》等法律法规，中国证监会决定对公司进行立案。 经公司自查发现，公司全资子公司北京科净源设备安装工程有限公司(以下简称"安装公司")存在对外担 保未及时履行审批程序和信息披露义务的情形。公司在发现上述对外担保事项后第一时间成立专项核查 小组，根据调查结果，对相关责任人员进行处罚，责令相关人员吸取教训、总结经验。要求公司所有部 门和全体员工高度重视，强化责任担当，认真履职。截至2024年3月31日，上述对外担保已经全部解除 完毕。 针对上述事项，公司及时进行了整改规范，具体整改措施如下： 1、解除全部子公司银行定期存单质押 截至2024年3月31日，公司前述银行定期存单质押已全部解除，公司不存在其他银行定期存单质押的情 形。 2、对相关人员进行内部问责 成立以董事长为组 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 2023年8月11日，科净源（维权）以"水环境治理领军企业"的光环登陆深交所创业板，发行价45元/股， 募集资金7.71亿元，上市首日股价一度冲高至128元/股，市值超40亿元。然而，这场资本盛宴仅持续了 20个月便宣告崩塌。2025年4月3日，科净源公告称因涉嫌信息披露违法违规被中国证监会立案调查，成 为创业板注册制下最快"暴雷"的上市公司之一。 业绩变脸速度创纪录 上市当年（2023年），科净源营收同比暴跌31.3%至3.02亿元，归母净利润仅1940万元，同比骤降 77.53%；2024年业绩进一步恶化，前三季度营收1.73亿元（同比-32.55%），归母净利润亏损3890万 元，同比下滑195.73%。这一"断崖式"下滑与招股书中"业务规模持续增长""盈利能力强劲"的表述形成 鲜明对比，被市场质疑为"带病上市"。 核心业务全线溃败 科净源主营水处理产品、水环境综合治理方案及运营服务，但三大业务板块均陷入困境： 水处理产品：2023年毛利率从50.26%骤降至40.76%，主因市场竞争加剧导致价格战； 综合治理项目：2024年存量项目回款周期延长至平均3 ...

Core Viewpoint - Ningxia Zhongke Biotechnology Co., Ltd. (*ST Ningke*) and its actual controller, Yu Jianming, received administrative penalties from the China Securities Regulatory Commission (CSRC) for violations related to information disclosure and financial reporting [1][2][10]. Group 1: Administrative Penalties - The CSRC issued two "Notice of Administrative Penalty" letters to *ST Ningke* and Yu Jianming on October 30, 2024, for suspected violations of information disclosure laws [1][2]. - On April 3, 2025, the CSRC confirmed the administrative penalties, which included a warning and fines totaling 5.5 million yuan for *ST Ningke* and various fines for responsible individuals [20][21][22]. Group 2: Violations Identified - *ST Ningke* was found to have inflated its 2022 revenue by 76.5941 million yuan and profit by 77.222 million yuan, constituting 11.25% and 46.59% of the reported figures, respectively [10]. - The company failed to timely disclose significant debts totaling 108 million yuan and the suspension of its subsidiary's operations, which were deemed major events under securities law [13][14]. Group 3: Responsible Individuals - Yu Jianming, as the actual controller, was found to have organized and directed the financial misreporting, leading to severe penalties [10][21]. - Other key individuals, including Huang Haisu (Chairman), Chen Rui (General Manager), and Dong Chunxiang (CFO), were also held accountable for their roles in the violations [11][14][20]. Group 4: Company Response and Future Actions - Following the penalties, *ST Ningke* has committed to improving compliance and internal controls to prevent future violations, emphasizing the importance of accurate and timely information disclosure [25][30]. - The company has expressed regret over the incident and is taking steps to enhance the understanding of relevant laws and regulations among its personnel [25][30].

Core Viewpoint - KJY has been investigated by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure regulations [3][5] Group 1: Investigation and Compliance - KJY received a notice from the CSRC indicating that it is under investigation for information disclosure violations [3] - The company conducted a self-examination and found that its wholly-owned subsidiary, Beijing KJY Equipment Installation Engineering Co., Ltd., failed to timely fulfill approval procedures and disclosure obligations regarding external guarantees [5] - KJY has taken corrective actions, including lifting all external guarantees and holding responsible personnel accountable [5] Group 2: Management Changes - Following the investigation, KJY's management has undergone changes, with the resignation of General Manager Li Chongxin and the appointment of Chairman Ge Jing as the new General Manager [7][10] - Li Chongxin's resignation was aimed at focusing on market management and development [10] Group 3: Financial Performance - KJY projected a net loss of between 99.34 million yuan and 141.39 million yuan for 2024, a significant decline from a profit of 19.4 million yuan in the previous year [12][13] - The company cited intensified market competition and a slowdown in project payment cycles as contributing factors to the expected losses [13] Group 4: Market Position - KJY has been operating in the water environment governance sector since its establishment in 2000 and is recognized as an innovative comprehensive service provider in this field [11]

文/梧桐兄弟 近期，退市公司鸿达兴业股份有限公司（400207，原代码002002）收到江苏证监局下发的《行政处罚事先告知书》，鸿达兴业退市之前涉及财务造假，虚增利润 总额逾40亿。 根据《行政处罚事先告知书》，2020年1月至2023年6月期间， 鸿达兴业通过篡改原始财务账套、指使审计人员虚构审计调整分录和篡改财务报表等方式，虚增营 业收入合计3,505,452,250.52元，虚增利润总额合计4,077,671,116.96元。 鸿达兴业主要生产主体内蒙古乌海化工有限公司（以下简称"乌海化工"）、内蒙古中谷矿业有限责任公司（以下简称"中谷矿业"）、西部环保有限公司（以下简 称"西部环保"，与乌海化工、中谷矿业统称为"乌海化工等三家子公司"）、内蒙古中科装备有限公司（以下简称"中科装备"）、包头市新达茂稀土有限公司（以下 简称"新达茂稀土"）等公司 已被法院裁定受理破产重整或破产清算。 此外，时任董事会秘书林少韩此次被罚款200万，而其已于2024年4月 因公司长期拖欠劳动报酬、未缴纳社会保险 辞职。 但与鸿达兴业投资者相比，公司股价由6-7元/股跌至不足1元，直至退市，谁欠谁呢？ 经查明，你们涉嫌存在以下 ...

Core Viewpoint - Several A-share companies are facing risk warnings due to violations related to false disclosures in their financial reports, leading to temporary trading suspensions and changes in stock designations to "ST" [1][4][7][11]. Group 1: Company Specifics - Xiangxue Pharmaceutical will be designated as "ST Xiangxue" after receiving a notice from the China Securities Regulatory Commission (CSRC) regarding false disclosures in its 2019 annual report, which included significant omissions related to related party non-operating fund occupation from 2016 to 2020 [4][6]. - Langyuan Co. will be designated as "ST Langyuan" following a similar notice from the Shandong Securities Regulatory Bureau, which identified false disclosures in its 2019 annual report, including inflated revenue and profits due to non-commercial contracts [8][9]. - Lianchuang Co. will also be designated as "ST Lianchuang" after receiving a notice indicating false disclosures in multiple reports from 2017 to 2019, particularly related to the acquisition of Shanghai Aotou and inflated financial figures [12][14]. Group 2: Regulatory Actions - The CSRC plans to impose penalties on Xiangxue Pharmaceutical, including a warning and a fine of 6 million yuan, along with individual fines for responsible parties [5][6]. - Langyuan Co. faces a proposed fine of 5 million yuan and individual penalties for executives, with significant market bans for key individuals [10]. - Lianchuang Co. is expected to receive a warning and a fine of 600,000 yuan, with severe penalties for responsible executives, including lifetime market bans for some [14].

文/飞云 12月5日，广道数字（839680.BJ）发布公告称，收到证监会下发的《立案告知书》。因公司涉嫌信息披露违法违规，中国证监会决定对公司立案。 此前，12月3日，北交所向广道数字发出问询函，问询公司询证函造假、应收账款等事项。据问询函披露， 1、个别媒体报道称你公司于年审期间，安排公司工作人员对会计师事务所 提供虚假收件电话 ，快递寄出后， 由你公司派人线下拦截询证函，私自加盖假公章 后，再寄回给会计师事务所，由此完成造假闭环。 请你公司就上述报道内容进行核实，是否存在拦截询证函、私盖公章、编制虚假询证函等情况。 请年审会计师说明年审函证发出方式、收回方式及控制过程，是否存在回函金额不符的情况，回函是否存在可疑情形，是否获取充分、适当的审计证据。 2、报道称，2018年至2022年，你公司应收账款余额持续上涨， 2022年底达到38263.07万元，较2018年底上涨25541.97万元。 2018 年至 2022 年公司应收账款占营 业收入比例逐年上升，处于较高水平， 在2022年达到 125.12%。 2022 年底，公司前五大客户的应收账款余额占当期末应收账款总余额的比例在99%以上。 请公司： ...

文/梧桐小新 12月3日，浙江证监局公布了对成龙建设集团有限公司及3名相关责任人员的行政处罚决定书。 | 序号 | 标题 | 文号 | 发文日期 | | --- | --- | --- | --- | | | 行政处罚决定书[2024]39号（成龙建设及相关 | | 2024-12-03 | | | 责任人员) | | | 经查，成龙建设以其广州分公司、温州分公司和福建分公司等三家分公司为主要造假实体， 通过虚构客户、虚构项目、伪造合同等虚构轨道交通板块和建设板块 相关购销业务，同时在公司财务部账套上增加虚假记账凭证生成虚假财务账套即信息披露的对应账套，实施财务造假。成龙建设将信息披露对应的账套、相关合 同等资料提供给审计机构等中介机构。四年累计虚增营业收入28,032,800,967.17元、累计虚增利润3,080,871,377.64元。 此外，成龙建设未按期披露2020年年度报告和2021年半年度报告。在"17成龙01""17成龙03""18成龙01"和"19成龙01"存续期内，成龙建设未在2020年结束之日起四 个月内披露2020年年度报告，未在2021年上半年结束之日起二个月内披露2021年半年度报 ...